Derval OCarroll - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Role
Officer
Signature
/s/ Christian Schmid, Attorney-in-Fact
Issuer symbol
IFRX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:08:51 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OCarroll Derval Officer C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY /s/ Christian Schmid, Attorney-in-Fact 18 Mar 2026 0002117350

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 20,000 $2.44 Direct F1
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 25,000 $2.37 Direct F2
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $1.79 Direct F3
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 70,000 $2.41 Direct F4
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 70,000 $1.17 Direct F5
holding IFRX Performance Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 21,000 $1.17 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 21, 2022 and is fully vested and exercisable as of the date hereof.
F2 This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
F3 This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
F4 This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
F5 This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 17,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
F6 This option shall vest depending upon achievement of the following performance criteria: (i) 50% shall vest if a certain financing event takes place before the fourth quarter of 2026 and (ii) 50% shall vest if the average Ordinary Share price for quarter four of 2026 exceeds $1.50.

Remarks:

Senior Vice President, Global Head of Regulatory Affairs and Compliance Exhibit List - Exhibit 24.1 Power of Attorney